Kratom Research Institute

Safety · 2026-05-01

Case Report: Kratom Use Drives Extreme Opioid Tolerance, Complicates ICU Pain Management

Source: Journal of Pain and Symptom Management

Why it matters

As kratom use rises and more users require hospital or ICU care, clinicians are encountering opioid tolerance of a magnitude not typically seen in patients without prior opioid prescriptions — requiring far higher doses and creating dangerous pain management scenarios that palliative care teams are unprepared for.

The big picture

Kratom's active alkaloids bind mu- and delta-opioid receptors, potentially causing cross-tolerance with pharmaceutical opioids. Until now, this interaction was primarily described in outpatient and addiction medicine settings. This case report is among the first to document severe cross-tolerance requiring ICU-level escalation, with the patient needing doses that would be fatal in an opioid-naïve individual. The case underscores the urgent need for routine kratom screening on hospital admission.

Key findings

What they say

"This case highlights the potential for kratom use to lead to opioid tolerance and withdrawal symptoms. Palliative care professionals should familiarize themselves with kratom's pharmacology and its potential to cause tolerance and withdrawal," the authors wrote.

Bottom line

**A dramatic ICU case shows chronic kratom use can produce severe cross-tolerance with standard opioids, requiring thousands of milligrams of morphine equivalents for pain control — a warning for every hospital admitting kratom users.**